Compugen (CGEN) Other Operating Expenses (2009 - 2026)
Compugen's (CGEN) quarterly Other Operating Expenses came in at $134000.0 in Q1 2026, down 3.6% year-on-year from $139000.0 in Q1 2025, and up 11.67% quarter-over-quarter from $120000.0 in Q4 2025.
Compugen (CGEN) Other Operating Expenses (2009 - 2026) Analysis & Trends
Compugen has disclosed Other Operating Expenses across 18 years of filings, most recently posting $134000.0 for Q1 2026.
- Other Operating Expenses for Q1 2026 came in at $134000.0, down 3.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $534000.0 (down 14.42% YoY), and the FY2025 annual result was $539000.0, down 6.42% from the prior year.
- Other Operating Expenses came in at $134000.0 for Q1 2026 at Compugen, up from $120000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $263000.0 in Q3 2022 to a low of $18000.0 in Q3 2023.
- The 5-year median for Other Operating Expenses is $139000.0 (2025), against an average of $142647.1.
- Across the five-year window, Other Operating Expenses slumped 93.16% in 2023 and soared 794.44% in 2024, its largest moves.
- Compugen's Other Operating Expenses stood at $191000.0 in 2022, then slumped by 68.06% to $61000.0 in 2023, then surged by 173.77% to $167000.0 in 2024, then decreased by 28.14% to $120000.0 in 2025, then increased by 11.67% to $134000.0 in 2026.
- The last three Other Operating Expenses figures came in at $134000.0 (Q1 2026), $120000.0 (Q4 2025), and $139000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 134,000.00 |
| Dec 31, 2025 | 120,000.00 |
| Sep 30, 2025 | 139,000.00 |
| Jun 30, 2025 | 141,000.00 |
| Mar 31, 2025 | 139,000.00 |
| Dec 31, 2024 | 167,000.00 |
| Sep 30, 2024 | 161,000.00 |
| Jun 30, 2024 | 157,000.00 |
| Mar 31, 2024 | 91,000.00 |
| Dec 31, 2023 | 61,000.00 |
| Sep 30, 2023 | 18,000.00 |
| Jun 30, 2023 | 49,000.00 |
| Mar 31, 2023 | 116,000.00 |
| Dec 31, 2022 | 191,000.00 |
| Sep 30, 2022 | 263,000.00 |
| Jun 30, 2022 | 255,000.00 |
| Mar 31, 2022 | 223,000.00 |
| Dec 31, 2021 | 211,000.00 |
| Sep 30, 2021 | 166,000.00 |
| Jun 30, 2021 | 241,000.00 |